1. Home
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Global Clinical Trial Outsourcing Market - Competition Forecast and Opportunities, 2027

Global Clinical Trial Outsourcing Market - Competition Forecast and Opportunities, 2027

  • October 2022
  • 115 pages
  • ID: 6325893
  • Format: PDF
  • TechSci Research


Table of Contents

Global Clinical Trial Outsourcing Market By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Therapeutic Area (Oncology, Hematology, Central Nervous System, Cardiovascular/Metabolic, Respiratory, Infectious Diseases, Immunology, Rare Diseases, Medical Devices, Others), By End User (Biotechnology & Pharmaceutical Companies, Medical Device Companies, Academic & Research Institutions) and By Region, Competition Forecast and Opportunities, 2027

Global clinical trial outsourcing market is anticipated to register robust growth with a significant CAGR in the forecast period, 2023-2027.Clinical trial outsourcing refers to the delegation of several duties involved in conducting clinical trials and related activities by the medical or pharmaceutical companies to indicate what works for the patient and what does not by testing them in a professional setup.

The market growth can be attributed to the rising need for new and advanced drugs and therapeutics to be tested and approved to address the rising prevalence of several life-threatening diseases.Moreover, the increasing investments in healthcare research and drug development activities are also adding to the market growth.

Outsourcing clinical trials offers several advantages to pharmaceutical and biotech companies such as cost efficiency, minimum timeline, timely result delivery, etc. As a result, pharmaceutical industries are increasingly opting for clinical trial outsourcing services to avail significant advantages in terms of cost as well as efficient drugs or vaccines.
Pharmaceutical companies are looking for ways to reduce overall expenses, for which they need to save costs in the research and development infrastructure and downsize their research staff.Therefore, pharma companies are outsourcing research and development work to a third party in order to increase the success rate, accelerate drug approvals and increase profits.

Moreover, growing investments by both private players and government authorities for the development of novel drugs and therapies are providing a boost to the global clinical trial outsourcing market.
In addition, the development of precision medicines is gaining wide traction in the healthcare sector.Precision medicine is a customized healthcare model that has tailored treatments and practices according to a patient’s molecular profiling and genetics.

Most of the clinical research outsourcing (CROs) providers are extensively working on developing precision medicine to reduce the overall cost of failure of a drug and develop effective therapy in less time.CROs provide guidance and support through all the stages of precision medicine trials.

As a result, several biotech and pharma companies are highly relying on such service providers for drug trials and approvals, which in turn, is adding to the growth of the global clinical trial outsourcing market.
Market Segmentation
The global clinical trial outsourcing market is segmented on the basis of clinical trial phase, therapeutic area, end user, competitive landscape, and regional distribution.On the basis of clinical trial phase, the market is segmented into Phase 0, Phase 1, Phase 3, and Phase 4.

Based on the therapeutic area, the market is fragmented into oncology, hematology, central nervous system, cardiovascular/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices, and others.By end user, the market is bifurcated between biotechnology & pharmaceutical companies, medical device companies, and academic & research institutions.

The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle east and Africa, South America. The United States is anticipated to hold a considerable market share in the coming years due to the presence of large market players in the region.
Company Profile
ICON plc. (PRA Health Sciences), PAREXEL International Corp., Thermo Fischer Scientific, Inc. (Pharmaceutical Product Development, LLC.), Sygnature Discovery Limited, WuXi AppTec Co., Ltd., Laboratory Corporation of America Holdings, Jubilant Biosys Limited, Charles River Laboratories International, Inc., Albany Molecular Research, Inc., and Syneos Health Inc are the leading market players of the global clinical trial outsourcing market.

Report Scope:

In this report, global Clinical Trial outsourcing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Clinical Trial Outsourcing Market, By Clinical Trial Phase:
o Phase 0
o Phase 1
o Phase 2
o Phase 3
o Phase 4
• Clinical Trial Outsourcing Market, By Therapeutic Area:
o Oncology
o Hematology
o Central Nervous System
o Cardiovascular/Metabolic
o Respiratory
o Infectious Diseases
o Immunology
o Rare Diseases
o Medical Devices
o Others
• Clinical Trial Outsourcing Market, By End Users:
o Biotechnology & Pharmaceutical Companies
o Medical Device Companies
o Academic & Research Institutions
• Clinical Trial outsourcing Market, By Region:
o North America
United States
o Europe
United Kingdom
o Asia Pacific
South Korea
o Middle East and Africa
Saudi Arabia
South Africa
o South America

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Clinical Trial Outsourcing Market.

Available Customizations:

With the given market data, we offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Electrophysiology Diagnostic Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • $ 2500
  • December 2022
  • 52 pages

Electrophysiology Diagnostic Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary Medical Devices sector report, ...

  • World
  • APAC
  • Clinical Trial
  • Electrophysiology Device
  • Company research
  • Company
  • Medical Technology Density
  • Diagnostic Revenue


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on